Drug
Ambroxol Hydrochloride
Ambroxol Hydrochloride is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
33%
Ph phase_2
3
50%
Ph phase_4
1
17%
Phase Distribution
2
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (33.3%)
Phase 23 (50.0%)
Phase 41 (16.7%)
Trials by Status
unknown117%
recruiting117%
completed350%
not_yet_recruiting117%
Recent Activity
1 active trials
Showing 5 of 6
completedphase_2
Ambroxol as a Disease-modifying Treatment in GBA-PD
NCT05287503
recruitingphase_1
High-Dose Ambroxol in GBA1-Related Parkinson
NCT06193421
completedphase_4
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
NCT05663905
not_yet_recruitingphase_1
Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
NCT04405596
unknownphase_2
GRoningen Early-PD Ambroxol Treatment
NCT05830396
Clinical Trials (6)
Showing 6 of 6 trials
NCT05287503Phase 2
Ambroxol as a Disease-modifying Treatment in GBA-PD
NCT06193421Phase 1
High-Dose Ambroxol in GBA1-Related Parkinson
NCT05663905Phase 4
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
NCT04405596Phase 1
Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
NCT05830396Phase 2
GRoningen Early-PD Ambroxol Treatment
NCT03415269Phase 2
A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6